Climb Bio (CLYM) Interest & Investment Income (2022 - 2026)

Climb Bio has reported Interest & Investment Income for 5 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 33.8% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (down 16.83% YoY), and the FY2025 full-year result was $8.3 million, up 2.35% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $1.5 million, down from $1.8 million in the prior quarter.
• The five-year high for Interest & Investment Income was $2.8 million in Q3 2024, with the low at $147000.0 in Q2 2022.
• Historically, Interest & Investment Income has averaged $1.5 million across 5 years, with a median of $1.4 million in 2023.
• Annual changes were most pronounced in 2023 — Interest & Investment Income soared 655.1% — and 2026, when it sank 33.8%.
• Climb Bio's Interest & Investment Income stood at $760000.0 in 2022, then surged by 77.5% to $1.3 million in 2023, then jumped by 86.88% to $2.5 million in 2024, then dropped by 27.57% to $1.8 million in 2025, then retreated by 17.09% to $1.5 million in 2026.
• The last three Interest & Investment Income figures came in at $1.5 million (Q1 2026), $1.8 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.